首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   156篇
  免费   27篇
  15篇
综合类   41篇
农作物   3篇
水产渔业   8篇
畜牧兽医   108篇
植物保护   8篇
  2021年   3篇
  2019年   3篇
  2018年   8篇
  2017年   5篇
  2016年   7篇
  2015年   8篇
  2013年   20篇
  2012年   6篇
  2011年   3篇
  2010年   4篇
  2009年   8篇
  2008年   6篇
  2007年   7篇
  2006年   11篇
  2005年   6篇
  2004年   5篇
  2003年   5篇
  2002年   5篇
  2001年   2篇
  2000年   2篇
  1999年   3篇
  1997年   1篇
  1996年   6篇
  1995年   1篇
  1993年   1篇
  1992年   1篇
  1991年   1篇
  1990年   2篇
  1989年   3篇
  1988年   5篇
  1987年   2篇
  1986年   3篇
  1985年   2篇
  1984年   1篇
  1982年   1篇
  1980年   1篇
  1977年   1篇
  1976年   1篇
  1974年   2篇
  1971年   3篇
  1969年   1篇
  1967年   3篇
  1965年   1篇
  1955年   1篇
  1948年   1篇
  1933年   2篇
  1931年   1篇
  1925年   1篇
  1905年   1篇
  1901年   2篇
排序方式: 共有183条查询结果,搜索用时 796 毫秒
1.
Sixty-one calves were electrically stunned with 100-250 V currents (103-1806 mA) and the prevalence and duration of insensibility was assessed from their physical behaviour, the presence of epileptiform activity in their electrocorticograms, and the absence of visual evoked responses in their electrocorticograms. A current applied at 100 V across the head for 3 s failed to induce insensibility in all cases. Currents at 150-250 V induced insensibility in all calves and the shortest duration of insensibility was 44 s. It is recommended that a 150-200 V current would be appropriate for commercial use.  相似文献   
2.
3.
REASONS FOR PERFORMING STUDY: Surveillance of equine influenza viruses has suggested that strains included in currently licensed vaccines are a poor match for those predominantly circulating in the field. OBJECTIVE: To assess the ability of Duvaxyn IE-T Plus to provide cross protection against the newly evolved South Africa/4/03 (H3N8) strain of equine influenza virus. METHODS: The vaccine efficacy was evaluated by challenge infection with influenza strain A/eq/South Africa/4/03 (H3N8) 2 weeks after a primary course of 2 vaccinations with Duvaxyn IE-T Plus given at a 4-week interval. The outcome of challenge in vaccinated ponies was compared with that in unvaccinated animals. RESULTS: At the time of challenge, all vaccinated ponies had high levels of antibody to Newmarket/1/93, Newmarket/2/93 and South Africa/4/03 strains measured by single radial haemolysis. After challenge infection, there were statistically significantly decreased clinical scores and virus shedding was significantly lower in the vaccinated ponies compared to unvaccinated controls. CONCLUSION: Two doses of Duvaxyn IE-T Plus provides good clinical and virological protection against challenge with a variant virus 2 weeks after the 2 doses of vaccine. POTENTIAL RELEVANCE: When variant strains of equine influenza virus first emerge, booster immunisations with currently available vaccines may limit infection provided sufficiently high antibody levels are achieved, suggesting that vaccination in the face of an outbreak may be beneficial.  相似文献   
4.
5.
6.
The objectives of this work were to determine the changes in the expression of neuroendocrine markers in Leydig cell by oestradiol treatment, and to determine whether testosterone is able to recover partially the effects of hormonal suppression induced by oestradiol. Adult male rats were injected daily with either 50 microg of oestradiol or oestradiol plus testosterone propionate (25 mg every 3 days) for 15 days. The animals were sacrificed and testicles were dissected and processed by routine histological protocols. FSH and LH serum levels were determined by radioimmunoassay. The visualization of antigens was achieved by the streptavidin-peroxidase immunohistochemical method. Antibodies against chromogranin A (CrA), S-100 protein (S-100), P substance (PS), synaptofisin (SYN), neurofilament protein (NF), gliofibrillary acidic protein (GFAP) and neuron specific enolase (NSE) were used. The mean LH and FSH serum concentrations were consistently suppressed with hormonal treatments. Intermediate filaments (NF and GFAP) showed no difference in their expression. The expression of S-100, NSE and SYN was significantly lower in both hormone-treated groups. In oestradiol-treated rats, the immunoreactivity of CrA and SP decreased significantly but was restored after testosterone supplementation. Although the nature and functions of many of these substances in Leydig cells remain unknown, these results are consistent with the hypothesis that the expression of some neuroendocrine markers is hormonally controlled.  相似文献   
7.
The state of Michigan has recognized the presence of Mycobacterium bovis in its free-ranging white-tailed deer population since 1994. This endemic infection is primarily located in a 12-county area in the northeastern lower peninsula of Michigan. A statewide surveillance and eradication program of the disease has been in effect since 1994. Worldwide, Mycobacterium tuberculosis complex organisms have a known predilection toward development of antimicrobial resistance. The objective of this study was to investigate the antimicrobial susceptibility of M. bovis isolates from white-tailed deer in Michigan and detect any changes in susceptibility over time. M. bovis isolates from 2 fall hunting seasons (1999 and 2004) were used in this study. The fall season of 2004 marked the first documented case of direct transmission of M. bovis from a wild deer to a human in Michigan. Since M. bovis is a zoonotic disease, knowledge of susceptibility can expedite treatment options in humans. M. bovis isolates were obtained from 58 deer, 4 coyotes, 3 cattle, 2 raccoons, and 1 human case from the 2 years combined. Methods of susceptibility testing included 1% proportion agar plates and Bactec radiometric broth testing. M. bovis was found to be uniformly resistant to the antibiotic pyrazinamide; this resistance is common to all M. bovis isolates. No other antimicrobial resistance was found in any of the tested M. bovis isolates, which may be, in part, attributed to the lack of any significant treatment pressure in wildlife.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号